期刊文献+

结肠癌组织中PKCβ1、COX-2及nm23-H1的表达及其意义 被引量:2

The expressions and clinical significance of PKCβ1,COX-2 and nm23-H1 in human colon cancer
下载PDF
导出
摘要 目的:研究结肠癌、结肠腺瘤和癌旁正常结肠粘膜组织中蛋白激酶C(PKCβ1)、环氧化酶-2(COX-2)及转移抑制基因nm23-H1的表达及其临床意义。方法:65例结肠癌、16例结肠腺瘤和8例癌旁结肠粘膜组织采用免疫组织化学法检测PKCβ1、COX-2及nm23-H1的表达。结果:PKCβ1表达在结肠癌与腺瘤和正常黏膜差异显著(P<0.01),表达率和表达强度依次递减。COX-2在结肠癌、结肠腺瘤和正常结肠粘膜组织中的表达差异显著,结肠癌组织中C0X-2的表达与结肠癌分化程度、淋巴结和远处转移以及Dukes分期有关,与年龄和性别无关。nm23-H1的表达在结肠癌、结肠腺瘤和正常结肠黏膜组织中差异有显著性(P<0.01),结肠癌组织中nm23-H1的表达与分化程度、远处转移及Dukes分期有关,但与其它临床病理资料无关。结论:PKCβ1可能与结肠黏膜上皮增生有关,可能参与了结肠的癌变过程,并可能在癌变早期发生改变。COX-2异常表达可能是结肠癌发生的早期事件,且在结肠癌的发生、发展中起一定作用。nm23-H1的表达下调,可促使结肠癌细胞获得进一步恶性分化及远处转移的潜能。 Objective:To study the expressions and clinical significance of PKC,COX-2 and nm23-H1 in human colon cancer,adenomatous polyps and normal para-cancer colon mucosa.Methods:Expressions of PKC,COX-2 and nm23-H1 proteins 65 cases of colon cancer,16 cases of adenomas and 8 cases of para-cancer mucosa were detected by immunohistochemical staining.Results:The expression of PKCβ1 in carcinoma tissues was significantly stronger than in adenoma and normal colon mucosa,and their expression rate and intensity were grad...
出处 《陕西医学杂志》 CAS 北大核心 2008年第2期167-168,176,共3页 Shaanxi Medical Journal
关键词 结肠肿瘤 蛋白激酶C 环氧水解酶类 @nm23-H1 Golon neoplasms Protein kinase C Epoxide hydrolases @nm23-H1
  • 相关文献

参考文献1

二级参考文献16

  • 1El-Zimaity HMT, Ramchatesingh J, Ali Saeed M, et al. Gastric intestinal metaplasia: subtypes and natural history [J]. J Clin Pathol, 2001, 54(9):679~683.
  • 2Bai YQ, Yamamoto H, Akiyama Y, et al. Ectopic expression of homeodomain protein CDX2 in intestinal meetplasia and carcinomas of the stomach[J]. Cancer Lett, 2002, 176(1):47~55.
  • 3Tahara E. Genetic pathways of two types of gastric cancer [J].IARC Sci Publ, 2004, 157:327~349.
  • 4Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma[J]. J Clin Gastroenterol, 2003, 36(5 Suppl):37~43.
  • 5Leung WK, SungJJ. Review article: intestinal metaplasia and gastric carcinogenesis[J]. Aliment Pharmacol Ther, 2002, 16(7):1209~1216.
  • 6Petersson F, Borch K, Franzen LE. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic auophic gastritis [J]. Scand J Gastroenterol,2002, 37 (3):262~266.
  • 7ConchilloJM, Houben G, de Bruine A, et al. Is type Ⅲ intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma[J]? EurJ Cancer Prey, 2001, 10(4): 307~312.
  • 8Morris CD, Armstrong GR, Bigley G, et al. Cyclooxygenase-2expression in the Barrett′s metaplasia-dysplasia-adenocarcinoma sequence[J]. AmJ Gastroenterol, 2001, 96(4): 990~996.
  • 9Piazuelo MB, Haque S, Delgado A, et al. Phenotypic differences between esophageal and gastric intestinal metaplasia [J]. Mod Pathol, 2004, 17(1):62~74.
  • 10Yamagata R, Shimoyama T, Fukuda S, et al. Cyclooxygenase-2expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia [J]. Eur J Gastroenterol Hepatol, 2002, 14(4):359~363.

共引文献12

同被引文献42

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部